Novartis Shareholders Give Green Light To Sandoz Spinoff

Separation Of Standalone Generics And Biosimilars Firm Expected To Proceed On 4 October

 
• By David Wallace
  
Traffic light on green
Novartis shareholders have given the go-ahead to spin off Sandoz • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business